CUSIP 21833P301COM NEWCRBPQ4 2025
31 filings · latest Feb 10, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Cormorant Asset Management, LP | 2.34M | $19.09M |
| 2 | Orbimed Advisors LLC | 1.60M | $13.00M |
| 3 | Aberdeen Group PLC | 1.32M | $10.76M |
| 4 | Octagon Capital Advisors LP | 955.0K | $7.77M |
| 5 | Vanguard Group Inc | 859.4K | $7.00M |
| 6 | Citadel Advisors LLC | 843.2K | $6.86M |
| 7 | Prosight Management, LP | 683.9K | $5.57M |
| 8 | Armistice Capital, LLC | 536.0K | $4.36M |
| 9 |
| 4 | Nov 14, 2025 | Cormorant Asset Management, LP | 13G/A | 12.8% | 2.38M | SEC |
| 5 | Nov 12, 2025 | Citadel Advisors LLC | 13G | 5.3% | 980.6K | SEC |
| 6 | Jul 29, 2025 | The Vanguard Group | 13G/A | 4.9% | 599.5K | SEC |
| 7 | Jul 16, 2025 | Blackrock, Inc. | 13G/A | 2.9% | 352.4K | SEC |
| 8 | Feb 14, 2025 | Orbimed Advisors LLC | 13G/A | 5.9% | 454.09B | SEC |
| 9 | Nov 14, 2024 | Tang Capital Management LLC | 13G/A | 5.0% | 600.0K | SEC |
| 10 | Nov 14, 2024 | Cormorant Asset Management, LP | 13G/A | 19.5% | 2.38M | SEC |
See the full Schedule 13D/13G history for Corbus Pharmaceuticals Hldgs.
Unlock full history| Stonepine Capital Management, LLC |
| 389.9K |
| $3.17M |
| 10 | Renaissance Technologies LLC | 354.3K | $2.88M |